MTOR and autism spectrum disorder: Targets for the mTOR antibody panel were selected based on four criteria: known relevance to mTOR signaling (Fig. S1A), known coassociations in at least one protein complex, as listed in BioGrid, IntACT, or specific literature searches (Fig. S1B); known association with autism spectrum disorder using the SFARI Gene database (queried in 2018); and the existence of suitable, commercially available antibodies.